

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | intestinal cholesterol absorption (GO:0030299) | 6.67487875 |
| 2 | intestinal absorption (GO:0050892) | 6.43623767 |
| 3 | Golgi transport vesicle coating (GO:0048200) | 6.11238710 |
| 4 | COPI coating of Golgi vesicle (GO:0048205) | 6.11238710 |
| 5 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 5.29948101 |
| 6 | endocrine pancreas development (GO:0031018) | 5.03278304 |
| 7 | COPII vesicle coating (GO:0048208) | 4.96326439 |
| 8 | desmosome organization (GO:0002934) | 4.74520404 |
| 9 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.53225789 |
| 10 | peptide hormone processing (GO:0016486) | 4.44111950 |
| 11 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 4.40360693 |
| 12 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.38775038 |
| 13 | L-phenylalanine catabolic process (GO:0006559) | 4.38775038 |
| 14 | sequestering of extracellular ligand from receptor (GO:0035581) | 4.30438177 |
| 15 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 4.21938257 |
| 16 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.19287430 |
| 17 | L-phenylalanine metabolic process (GO:0006558) | 4.19287430 |
| 18 | protein retention in ER lumen (GO:0006621) | 3.98704618 |
| 19 | cell adhesion mediated by integrin (GO:0033627) | 3.96008187 |
| 20 | glandular epithelial cell differentiation (GO:0002067) | 3.91096957 |
| 21 | glucuronate metabolic process (GO:0019585) | 3.89378593 |
| 22 | uronic acid metabolic process (GO:0006063) | 3.89378593 |
| 23 | regulation of bile acid biosynthetic process (GO:0070857) | 3.87838243 |
| 24 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.87712491 |
| 25 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.87712491 |
| 26 | intestinal epithelial cell development (GO:0060576) | 3.85247957 |
| 27 | transcytosis (GO:0045056) | 3.83249541 |
| 28 | sulfur amino acid catabolic process (GO:0000098) | 3.80500031 |
| 29 | actin filament depolymerization (GO:0030042) | 3.79746207 |
| 30 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.72155808 |
| 31 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.71137840 |
| 32 | endocardial cushion development (GO:0003197) | 3.70399772 |
| 33 | regulation of cholesterol homeostasis (GO:2000188) | 3.69693320 |
| 34 | homocysteine metabolic process (GO:0050667) | 3.68449160 |
| 35 | renal filtration (GO:0097205) | 3.64787292 |
| 36 | adhesion of symbiont to host cell (GO:0044650) | 3.63578431 |
| 37 | virion attachment to host cell (GO:0019062) | 3.63578431 |
| 38 | phospholipid efflux (GO:0033700) | 3.58835886 |
| 39 | skin morphogenesis (GO:0043589) | 3.57999917 |
| 40 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.56707008 |
| 41 | regulation of transforming growth factor beta1 production (GO:0032908) | 3.56617472 |
| 42 | angiotensin maturation (GO:0002003) | 3.54665594 |
| 43 | hormone catabolic process (GO:0042447) | 3.54072094 |
| 44 | exocrine pancreas development (GO:0031017) | 3.52248382 |
| 45 | sulfate transmembrane transport (GO:1902358) | 3.49755520 |
| 46 | * bile acid and bile salt transport (GO:0015721) | 3.47643628 |
| 47 | aromatic amino acid family catabolic process (GO:0009074) | 3.46181705 |
| 48 | renal system process involved in regulation of blood volume (GO:0001977) | 3.42873282 |
| 49 | lipoprotein metabolic process (GO:0042157) | 3.40667176 |
| 50 | high-density lipoprotein particle remodeling (GO:0034375) | 3.40319702 |
| 51 | drug catabolic process (GO:0042737) | 3.38593773 |
| 52 | glomerular filtration (GO:0003094) | 3.36775344 |
| 53 | signal peptide processing (GO:0006465) | 3.35830004 |
| 54 | positive regulation of nuclease activity (GO:0032075) | 3.35299709 |
| 55 | reverse cholesterol transport (GO:0043691) | 3.34524069 |
| 56 | chondrocyte proliferation (GO:0035988) | 3.33246059 |
| 57 | flavonoid metabolic process (GO:0009812) | 3.28097332 |
| 58 | collagen fibril organization (GO:0030199) | 3.24621161 |
| 59 | digestive system process (GO:0022600) | 3.23757862 |
| 60 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 3.23697711 |
| 61 | response to hepatocyte growth factor (GO:0035728) | 3.23697711 |
| 62 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.23077441 |
| 63 | urea metabolic process (GO:0019627) | 3.22641971 |
| 64 | urea cycle (GO:0000050) | 3.22641971 |
| 65 | sequestering of metal ion (GO:0051238) | 3.20766710 |
| 66 | acylglycerol homeostasis (GO:0055090) | 3.19109408 |
| 67 | triglyceride homeostasis (GO:0070328) | 3.19109408 |
| 68 | cellular response to vitamin (GO:0071295) | 3.19097335 |
| 69 | cholesterol efflux (GO:0033344) | 3.18955655 |
| 70 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.18587346 |
| 71 | digestion (GO:0007586) | 3.16519580 |
| 72 | negative regulation of fatty acid transport (GO:2000192) | 3.15918621 |
| 73 | negative regulation of digestive system process (GO:0060457) | 3.15158646 |
| 74 | hypotonic response (GO:0006971) | 3.15136434 |
| 75 | O-glycan processing (GO:0016266) | 3.14948376 |
| 76 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.14385262 |
| 77 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.13335638 |
| 78 | vesicle coating (GO:0006901) | 3.12511028 |
| 79 | regulation of triglyceride catabolic process (GO:0010896) | 3.12378758 |
| 80 | cysteine metabolic process (GO:0006534) | 3.10581821 |
| 81 | columnar/cuboidal epithelial cell development (GO:0002066) | 3.09511073 |
| 82 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 3.09502201 |
| 83 | hemidesmosome assembly (GO:0031581) | 3.09457419 |
| 84 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.08497608 |
| 85 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.08496077 |
| 86 | plasma lipoprotein particle assembly (GO:0034377) | 3.08438631 |
| 87 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.08268912 |
| 88 | protein carboxylation (GO:0018214) | 3.08268912 |
| 89 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.08164132 |
| 90 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.05850891 |
| 91 | epithelial cell-cell adhesion (GO:0090136) | 3.05566994 |
| 92 | endodermal cell differentiation (GO:0035987) | 3.04104257 |
| 93 | regulation of cholesterol esterification (GO:0010872) | 3.02503961 |
| 94 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.02382507 |
| 95 | positive regulation of glycolytic process (GO:0045821) | 3.02177090 |
| 96 | adhesion of symbiont to host (GO:0044406) | 3.02023022 |
| 97 | regulation of nuclease activity (GO:0032069) | 3.00459081 |
| 98 | 4-hydroxyproline metabolic process (GO:0019471) | 2.98966188 |
| 99 | cellular response to unfolded protein (GO:0034620) | 2.98254493 |
| 100 | sulfate transport (GO:0008272) | 2.97865409 |
| 101 | type B pancreatic cell development (GO:0003323) | 2.97203150 |
| 102 | protein-lipid complex remodeling (GO:0034368) | 2.96510914 |
| 103 | macromolecular complex remodeling (GO:0034367) | 2.96510914 |
| 104 | plasma lipoprotein particle remodeling (GO:0034369) | 2.96510914 |
| 105 | cholesterol homeostasis (GO:0042632) | 2.95979629 |
| 106 | sterol homeostasis (GO:0055092) | 2.95814106 |
| 107 | phospholipid homeostasis (GO:0055091) | 2.95513056 |
| 108 | cholesterol transport (GO:0030301) | 2.94975934 |
| 109 | sterol transport (GO:0015918) | 2.94975934 |
| 110 | nitrogen cycle metabolic process (GO:0071941) | 2.93123454 |
| 111 | wound healing, spreading of epidermal cells (GO:0035313) | 2.92939104 |
| 112 | sphingomyelin metabolic process (GO:0006684) | 2.91105335 |
| 113 | epoxygenase P450 pathway (GO:0019373) | 2.90685609 |
| 114 | ER-nucleus signaling pathway (GO:0006984) | 2.89943246 |
| 115 | negative regulation of sterol transport (GO:0032372) | 2.88203100 |
| 116 | negative regulation of cholesterol transport (GO:0032375) | 2.88203100 |
| 117 | alpha-linolenic acid metabolic process (GO:0036109) | 2.86714659 |
| 118 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.86353887 |
| 119 | protein-lipid complex assembly (GO:0065005) | 2.83358466 |
| 120 | extracellular matrix assembly (GO:0085029) | 2.83200510 |
| 121 | cellular response to vitamin D (GO:0071305) | 2.82878733 |
| 122 | type B pancreatic cell proliferation (GO:0044342) | 2.82595821 |
| 123 | macroautophagy (GO:0016236) | 2.82223773 |
| 124 | regulation of protein activation cascade (GO:2000257) | 2.80337053 |
| 125 | cellular response to topologically incorrect protein (GO:0035967) | 2.79745886 |
| 126 | nucleotide-sugar metabolic process (GO:0009225) | 2.79708617 |
| 127 | protein maturation by protein folding (GO:0022417) | 2.78316183 |
| 128 | cellular glucuronidation (GO:0052695) | 2.77620585 |
| 129 | bile acid biosynthetic process (GO:0006699) | 2.77074127 |
| 130 | tryptophan metabolic process (GO:0006568) | 2.76164516 |
| 131 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.76032312 |
| 132 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 2.75539316 |
| 133 | blood vessel maturation (GO:0001955) | 2.74240641 |
| 134 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.73506936 |
| 135 | * bile acid metabolic process (GO:0008206) | 2.73315978 |
| 136 | endocrine process (GO:0050886) | 2.73122202 |
| 137 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.73122202 |
| 138 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 2.73122202 |
| 139 | complement activation, alternative pathway (GO:0006957) | 2.72225444 |
| 140 | oligosaccharide biosynthetic process (GO:0009312) | 2.72017210 |
| 141 | extracellular negative regulation of signal transduction (GO:1900116) | 2.71921715 |
| 142 | extracellular regulation of signal transduction (GO:1900115) | 2.71921715 |
| 143 | protein autoprocessing (GO:0016540) | 2.71011205 |
| 144 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.70073469 |
| 145 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.68910194 |
| 146 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.65644892 |
| 147 | gap junction assembly (GO:0016264) | 2.64428911 |
| 148 | lymphangiogenesis (GO:0001946) | 2.63455091 |
| 149 | cell-substrate junction assembly (GO:0007044) | 2.62460170 |
| 150 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.60217668 |
| 151 | smooth muscle tissue development (GO:0048745) | 2.57279242 |
| 152 | negative regulation of anoikis (GO:2000811) | 2.56861512 |
| 153 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.56314333 |
| 154 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.55792821 |
| 155 | protein localization to endosome (GO:0036010) | 2.54469624 |
| 156 | protein heterotrimerization (GO:0070208) | 2.52430118 |
| 157 | regulation of metalloenzyme activity (GO:0048552) | 2.51993926 |
| 158 | tight junction assembly (GO:0070830) | 2.51559832 |
| 159 | ethanol oxidation (GO:0006069) | 2.51289619 |
| 160 | ethanol metabolic process (GO:0006067) | 2.51094379 |
| 161 | positive regulation of pseudopodium assembly (GO:0031274) | 2.47976007 |
| 162 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.47934652 |
| 163 | bone trabecula formation (GO:0060346) | 2.47046769 |
| 164 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.46732881 |
| 165 | regulation of systemic arterial blood pressure (GO:0003073) | 2.46262416 |
| 166 | membrane protein ectodomain proteolysis (GO:0006509) | 2.45387620 |
| 167 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 2.44592200 |
| 168 | regulation of extracellular matrix disassembly (GO:0010715) | 2.44433788 |
| 169 | regulation of plasminogen activation (GO:0010755) | 2.43759094 |
| 170 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.43693330 |
| 171 | positive regulation of fatty acid oxidation (GO:0046321) | 2.43605743 |
| 172 | regulation of guanylate cyclase activity (GO:0031282) | 2.42948634 |
| 173 | barbed-end actin filament capping (GO:0051016) | 2.42813553 |
| 174 | wound healing, spreading of cells (GO:0044319) | 2.41812825 |
| 175 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.41762160 |
| 176 | basement membrane organization (GO:0071711) | 2.40227303 |
| 177 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.40149394 |
| 178 | primary alcohol catabolic process (GO:0034310) | 2.39893491 |
| 179 | multicellular organismal water homeostasis (GO:0050891) | 2.39458916 |
| 180 | negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394) | 2.38262157 |
| 181 | multicellular organismal metabolic process (GO:0044236) | 2.37859196 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.55486594 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.04055591 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.52015801 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.50147944 |
| 5 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.30487782 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.49948379 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.49093695 |
| 8 | GATA1_22025678_ChIP-Seq_K562_Human | 3.25817664 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.16349991 |
| 10 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.11550094 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.98658727 |
| 12 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.69242088 |
| 13 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.64588880 |
| 14 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.49288837 |
| 15 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.23809231 |
| 16 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.10798631 |
| 17 | * CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.07058562 |
| 18 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.01227001 |
| 19 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.97065360 |
| 20 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.92692931 |
| 21 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.92338777 |
| 22 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.85861460 |
| 23 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.85627158 |
| 24 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.81267033 |
| 25 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.76434583 |
| 26 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.71968634 |
| 27 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.71269293 |
| 28 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.70524096 |
| 29 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.68734583 |
| 30 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.67443622 |
| 31 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.63839283 |
| 32 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.58717483 |
| 33 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.58007854 |
| 34 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.56202441 |
| 35 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.55904238 |
| 36 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.55627799 |
| 37 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.53261485 |
| 38 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.50753197 |
| 39 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.45601947 |
| 40 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.44749134 |
| 41 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.43203507 |
| 42 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.41817674 |
| 43 | TP53_16413492_ChIP-PET_HCT116_Human | 1.40109584 |
| 44 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.36538997 |
| 45 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.34621673 |
| 46 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.34511423 |
| 47 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.34302640 |
| 48 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.29605363 |
| 49 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.28527691 |
| 50 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.27910728 |
| 51 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.26771957 |
| 52 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.24699740 |
| 53 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.21334383 |
| 54 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.20509395 |
| 55 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.19489834 |
| 56 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.18678197 |
| 57 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.18256951 |
| 58 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.16413993 |
| 59 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.15808922 |
| 60 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.15319328 |
| 61 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.13213006 |
| 62 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.09265300 |
| 63 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06765179 |
| 64 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.05706844 |
| 65 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.04014458 |
| 66 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.03393496 |
| 67 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.02465571 |
| 68 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.02465571 |
| 69 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02385505 |
| 70 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.00327522 |
| 71 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.99707791 |
| 72 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.99644706 |
| 73 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.98147957 |
| 74 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97368019 |
| 75 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.97219792 |
| 76 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.97091410 |
| 77 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.96465610 |
| 78 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.96360567 |
| 79 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.96256529 |
| 80 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.96053741 |
| 81 | GATA1_19941826_ChIP-Seq_K562_Human | 0.95866746 |
| 82 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.95270307 |
| 83 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94393410 |
| 84 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.94060726 |
| 85 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.93485556 |
| 86 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.92930308 |
| 87 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.92147317 |
| 88 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.91413373 |
| 89 | * EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.91093850 |
| 90 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.91069754 |
| 91 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89167588 |
| 92 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.87601200 |
| 93 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.86844662 |
| 94 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.85949655 |
| 95 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.84676076 |
| 96 | RXR_22108803_ChIP-Seq_LS180_Human | 0.84628050 |
| 97 | ATF3_27146783_Chip-Seq_COLON_Human | 0.84589335 |
| 98 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.84565763 |
| 99 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.83934329 |
| 100 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.82968801 |
| 101 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.82935626 |
| 102 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.82144446 |
| 103 | GATA2_19941826_ChIP-Seq_K562_Human | 0.81929876 |
| 104 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.80643386 |
| 105 | CJUN_26792858_Chip-Seq_BT549_Human | 0.80134128 |
| 106 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.79315452 |
| 107 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.77381449 |
| 108 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.74669485 |
| 109 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.73232872 |
| 110 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.71834746 |
| 111 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.70420605 |
| 112 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.69940104 |
| 113 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.69635394 |
| 114 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.69037531 |
| 115 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.69037531 |
| 116 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.68672519 |
| 117 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.68527777 |
| 118 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.67123845 |
| 119 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.66725468 |
| 120 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.65545528 |
| 121 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.65188068 |
| 122 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.64984929 |
| 123 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.64504854 |
| 124 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.63512781 |
| 125 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.62049338 |
| 126 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.61916385 |
| 127 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.61916385 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.36761103 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 5.17392937 |
| 3 | MP0008438_abnormal_cutaneous_collagen | 5.00641117 |
| 4 | MP0001666_abnormal_nutrient_absorption | 4.30853315 |
| 5 | * MP0005085_abnormal_gallbladder_physiolo | 3.93985268 |
| 6 | * MP0005365_abnormal_bile_salt | 3.91243099 |
| 7 | MP0005275_abnormal_skin_tensile | 3.15531546 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 3.03328217 |
| 9 | MP0004264_abnormal_extraembryonic_tissu | 2.97649216 |
| 10 | MP0003195_calcinosis | 2.95706823 |
| 11 | MP0002877_abnormal_melanocyte_morpholog | 2.89798349 |
| 12 | MP0005503_abnormal_tendon_morphology | 2.82181246 |
| 13 | MP0004043_abnormal_pH_regulation | 2.80347863 |
| 14 | MP0003283_abnormal_digestive_organ | 2.76920442 |
| 15 | MP0004272_abnormal_basement_membrane | 2.74741992 |
| 16 | * MP0003252_abnormal_bile_duct | 2.71761054 |
| 17 | MP0001958_emphysema | 2.67283898 |
| 18 | MP0003868_abnormal_feces_composition | 2.62317702 |
| 19 | MP0003279_aneurysm | 2.61496161 |
| 20 | MP0003566_abnormal_cell_adhesion | 2.55451577 |
| 21 | MP0010234_abnormal_vibrissa_follicle | 2.54606548 |
| 22 | MP0009780_abnormal_chondrocyte_physiolo | 2.53780309 |
| 23 | MP0010329_abnormal_lipoprotein_level | 2.35617023 |
| 24 | MP0002693_abnormal_pancreas_physiology | 2.35096995 |
| 25 | MP0005257_abnormal_intraocular_pressure | 2.33642914 |
| 26 | MP0000462_abnormal_digestive_system | 2.33113529 |
| 27 | MP0003950_abnormal_plasma_membrane | 2.31970342 |
| 28 | MP0003941_abnormal_skin_development | 2.25564991 |
| 29 | MP0003300_gastrointestinal_ulcer | 2.22094504 |
| 30 | MP0003806_abnormal_nucleotide_metabolis | 2.20895731 |
| 31 | MP0005220_abnormal_exocrine_pancreas | 2.18981581 |
| 32 | MP0001944_abnormal_pancreas_morphology | 2.14086019 |
| 33 | MP0009840_abnormal_foam_cell | 2.10181647 |
| 34 | MP0003183_abnormal_peptide_metabolism | 2.04454500 |
| 35 | MP0005083_abnormal_biliary_tract | 2.02539917 |
| 36 | MP0005023_abnormal_wound_healing | 2.00975682 |
| 37 | MP0010386_abnormal_urinary_bladder | 1.91566281 |
| 38 | MP0002909_abnormal_adrenal_gland | 1.90249563 |
| 39 | MP0006054_spinal_hemorrhage | 1.88333912 |
| 40 | MP0000013_abnormal_adipose_tissue | 1.85284344 |
| 41 | MP0009643_abnormal_urine_homeostasis | 1.77152631 |
| 42 | MP0000678_abnormal_parathyroid_gland | 1.73104975 |
| 43 | MP0002138_abnormal_hepatobiliary_system | 1.72083366 |
| 44 | MP0005623_abnormal_meninges_morphology | 1.69979963 |
| 45 | MP0003091_abnormal_cell_migration | 1.68405910 |
| 46 | MP0005332_abnormal_amino_acid | 1.65908198 |
| 47 | MP0002078_abnormal_glucose_homeostasis | 1.62428476 |
| 48 | MP0002118_abnormal_lipid_homeostasis | 1.59482358 |
| 49 | MP0004019_abnormal_vitamin_homeostasis | 1.58518333 |
| 50 | MP0005379_endocrine/exocrine_gland_phen | 1.57503519 |
| 51 | MP0005409_darkened_coat_color | 1.52929160 |
| 52 | MP0001542_abnormal_bone_strength | 1.50710559 |
| 53 | MP0003866_abnormal_defecation | 1.42909173 |
| 54 | * MP0000609_abnormal_liver_physiology | 1.42143650 |
| 55 | MP0000767_abnormal_smooth_muscle | 1.40740859 |
| 56 | MP0001765_abnormal_ion_homeostasis | 1.40456769 |
| 57 | MP0005084_abnormal_gallbladder_morpholo | 1.32597394 |
| 58 | MP0000538_abnormal_urinary_bladder | 1.31063448 |
| 59 | MP0005636_abnormal_mineral_homeostasis | 1.29977954 |
| 60 | MP0000613_abnormal_salivary_gland | 1.29773791 |
| 61 | MP0004782_abnormal_surfactant_physiolog | 1.28904659 |
| 62 | MP0001664_abnormal_digestion | 1.27647064 |
| 63 | MP0003191_abnormal_cellular_cholesterol | 1.25739271 |
| 64 | MP0000534_abnormal_ureter_morphology | 1.21086153 |
| 65 | MP0004858_abnormal_nervous_system | 1.20982472 |
| 66 | MP0002896_abnormal_bone_mineralization | 1.20533842 |
| 67 | MP0003705_abnormal_hypodermis_morpholog | 1.18066261 |
| 68 | MP0001756_abnormal_urination | 1.17735936 |
| 69 | MP0005501_abnormal_skin_physiology | 1.16200494 |
| 70 | MP0005595_abnormal_vascular_smooth | 1.15200495 |
| 71 | MP0000003_abnormal_adipose_tissue | 1.14935536 |
| 72 | MP0008004_abnormal_stomach_pH | 1.08901344 |
| 73 | MP0002837_dystrophic_cardiac_calcinosis | 1.08442348 |
| 74 | MP0001879_abnormal_lymphatic_vessel | 1.07169367 |
| 75 | MP0005448_abnormal_energy_balance | 1.07159637 |
| 76 | MP0001243_abnormal_dermal_layer | 1.07146286 |
| 77 | MP0002168_other_aberrant_phenotype | 1.05568832 |
| 78 | MP0005408_hypopigmentation | 1.03402628 |
| 79 | MP0005508_abnormal_skeleton_morphology | 1.03336402 |
| 80 | MP0003953_abnormal_hormone_level | 1.03019013 |
| 81 | MP0002876_abnormal_thyroid_physiology | 1.02909746 |
| 82 | MP0005165_increased_susceptibility_to | 1.00908677 |
| 83 | MP0000762_abnormal_tongue_morphology | 0.98910771 |
| 84 | MP0005381_digestive/alimentary_phenotyp | 0.98707241 |
| 85 | MP0002928_abnormal_bile_duct | 0.98649113 |
| 86 | MP0002254_reproductive_system_inflammat | 0.92069554 |
| 87 | MP0001764_abnormal_homeostasis | 0.91570551 |
| 88 | * MP0005319_abnormal_enzyme/_coenzyme | 0.88716224 |
| 89 | MP0004134_abnormal_chest_morphology | 0.83625185 |
| 90 | MP0002060_abnormal_skin_morphology | 0.83121553 |
| 91 | MP0000427_abnormal_hair_cycle | 0.82488606 |
| 92 | MP0001216_abnormal_epidermal_layer | 0.82187553 |
| 93 | * MP0009642_abnormal_blood_homeostasis | 0.80753993 |
| 94 | MP0001849_ear_inflammation | 0.79995326 |
| 95 | MP0005164_abnormal_response_to | 0.79693971 |
| 96 | MP0009379_abnormal_foot_pigmentation | 0.79253515 |
| 97 | MP0002166_altered_tumor_susceptibility | 0.79120642 |
| 98 | MP0000230_abnormal_systemic_arterial | 0.78712709 |
| 99 | MP0010155_abnormal_intestine_physiology | 0.78675949 |
| 100 | MP0002108_abnormal_muscle_morphology | 0.78138569 |
| 101 | MP0000627_abnormal_mammary_gland | 0.77962047 |
| 102 | MP0009384_cardiac_valve_regurgitation | 0.77580401 |
| 103 | MP0001661_extended_life_span | 0.77392970 |
| 104 | MP0002295_abnormal_pulmonary_circulatio | 0.77356824 |
| 105 | MP0000477_abnormal_intestine_morphology | 0.76613668 |
| 106 | MP0002234_abnormal_pharynx_morphology | 0.75283468 |
| 107 | MP0000537_abnormal_urethra_morphology | 0.72186623 |
| 108 | MP0005670_abnormal_white_adipose | 0.72154267 |
| 109 | MP0000470_abnormal_stomach_morphology | 0.72085449 |
| 110 | MP0003045_fibrosis | 0.72027165 |
| 111 | MP0008961_abnormal_basal_metabolism | 0.71813576 |
| 112 | MP0000490_abnormal_crypts_of | 0.71396739 |
| 113 | MP0001663_abnormal_digestive_system | 0.70482247 |
| 114 | MP0010368_abnormal_lymphatic_system | 0.70323974 |
| 115 | MP0005375_adipose_tissue_phenotype | 0.68649096 |
| 116 | MP0005334_abnormal_fat_pad | 0.68520361 |
| 117 | MP0010771_integument_phenotype | 0.68244287 |
| 118 | MP0000163_abnormal_cartilage_morphology | 0.68117427 |
| 119 | MP0001881_abnormal_mammary_gland | 0.67998784 |
| 120 | MP0005166_decreased_susceptibility_to | 0.67344850 |
| 121 | MP0000465_gastrointestinal_hemorrhage | 0.66787407 |
| 122 | MP0005058_abnormal_lysosome_morphology | 0.65855359 |
| 123 | MP0005187_abnormal_penis_morphology | 0.65542550 |
| 124 | MP0000733_abnormal_muscle_development | 0.64955047 |
| 125 | MP0002009_preneoplasia | 0.64832257 |
| 126 | MP0002098_abnormal_vibrissa_morphology | 0.64281192 |
| 127 | MP0009053_abnormal_anal_canal | 0.64028258 |
| 128 | MP0005535_abnormal_body_temperature | 0.62873395 |
| 129 | MP0000579_abnormal_nail_morphology | 0.62145343 |
| 130 | MP0003959_abnormal_lean_body | 0.61902091 |
| 131 | MP0001873_stomach_inflammation | 0.60612255 |
| 132 | MP0005310_abnormal_salivary_gland | 0.60206970 |
| 133 | * MP0000598_abnormal_liver_morphology | 0.59166459 |
| 134 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.58799429 |
| 135 | MP0002796_impaired_skin_barrier | 0.57278319 |
| 136 | MP0005248_abnormal_Harderian_gland | 0.57125887 |
| 137 | MP0004185_abnormal_adipocyte_glucose | 0.57085878 |
| 138 | MP0010352_gastrointestinal_tract_polyps | 0.54697278 |
| 139 | MP0000516_abnormal_urinary_system | 0.54243856 |
| 140 | MP0005367_renal/urinary_system_phenotyp | 0.54243856 |
| 141 | MP0002136_abnormal_kidney_physiology | 0.53338357 |
| 142 | MP0005167_abnormal_blood-brain_barrier | 0.53159456 |
| 143 | MP0003119_abnormal_digestive_system | 0.52967071 |
| 144 | MP0005666_abnormal_adipose_tissue | 0.52844031 |
| 145 | MP0010678_abnormal_skin_adnexa | 0.52770069 |
| 146 | MP0000467_abnormal_esophagus_morphology | 0.52724291 |
| 147 | MP0009697_abnormal_copulation | 0.51293971 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperinsulinemic hypoglycemia (HP:0000825) | 6.13936895 |
| 2 | Hypoglycemic coma (HP:0001325) | 6.09364508 |
| 3 | Hypoglycemic seizures (HP:0002173) | 5.99197384 |
| 4 | Premature rupture of membranes (HP:0001788) | 5.61080865 |
| 5 | Symptomatic seizures (HP:0011145) | 5.46851725 |
| 6 | Protrusio acetabuli (HP:0003179) | 5.24098117 |
| 7 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.66707596 |
| 8 | Aortic dissection (HP:0002647) | 4.64691938 |
| 9 | Aortic aneurysm (HP:0004942) | 4.58973453 |
| 10 | Hyperglycemia (HP:0003074) | 4.53337875 |
| 11 | Ketoacidosis (HP:0001993) | 4.38782441 |
| 12 | Neonatal short-limb short stature (HP:0008921) | 4.23378362 |
| 13 | Flat acetabular roof (HP:0003180) | 4.20603066 |
| 14 | Abnormality of the intrinsic pathway (HP:0010989) | 4.20451263 |
| 15 | Hypobetalipoproteinemia (HP:0003563) | 4.20092687 |
| 16 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 4.13066971 |
| 17 | Vascular tortuosity (HP:0004948) | 3.95591866 |
| 18 | Late onset (HP:0003584) | 3.94208762 |
| 19 | Xanthomatosis (HP:0000991) | 3.93538611 |
| 20 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.86498819 |
| 21 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.86498819 |
| 22 | Abnormality of the common coagulation pathway (HP:0010990) | 3.81231038 |
| 23 | Arterial tortuosity (HP:0005116) | 3.80146286 |
| 24 | Ileus (HP:0002595) | 3.76159145 |
| 25 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.75082472 |
| 26 | * Intrahepatic cholestasis (HP:0001406) | 3.60944605 |
| 27 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.52207926 |
| 28 | Ketosis (HP:0001946) | 3.48059163 |
| 29 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.46611678 |
| 30 | Broad metatarsal (HP:0001783) | 3.42105059 |
| 31 | Prolonged partial thromboplastin time (HP:0003645) | 3.40275424 |
| 32 | Cardiovascular calcification (HP:0011915) | 3.37751538 |
| 33 | Deep venous thrombosis (HP:0002625) | 3.35203444 |
| 34 | Cervical subluxation (HP:0003308) | 3.33399217 |
| 35 | * Fat malabsorption (HP:0002630) | 3.30879184 |
| 36 | Abdominal distention (HP:0003270) | 3.28938699 |
| 37 | Ankle contracture (HP:0006466) | 3.18895408 |
| 38 | Right ventricular cardiomyopathy (HP:0011663) | 3.15913832 |
| 39 | Hypolipoproteinemia (HP:0010981) | 3.12472930 |
| 40 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.07280566 |
| 41 | Osteolytic defects of the hand bones (HP:0009699) | 3.07280566 |
| 42 | Atrophic scars (HP:0001075) | 3.06628375 |
| 43 | Acanthocytosis (HP:0001927) | 3.02793549 |
| 44 | * Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.01497731 |
| 45 | Epidermoid cyst (HP:0200040) | 2.95118699 |
| 46 | Generalized aminoaciduria (HP:0002909) | 2.92969911 |
| 47 | Follicular hyperkeratosis (HP:0007502) | 2.90184053 |
| 48 | Wormian bones (HP:0002645) | 2.89142027 |
| 49 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.85930707 |
| 50 | Mucopolysacchariduria (HP:0008155) | 2.85930707 |
| 51 | Skin nodule (HP:0200036) | 2.85283955 |
| 52 | Fragile skin (HP:0001030) | 2.83932037 |
| 53 | Abnormality of purine metabolism (HP:0004352) | 2.83079273 |
| 54 | Insulin resistance (HP:0000855) | 2.82289610 |
| 55 | Thin bony cortex (HP:0002753) | 2.82259488 |
| 56 | Soft skin (HP:0000977) | 2.81904305 |
| 57 | Abnormal pancreas size (HP:0012094) | 2.77987935 |
| 58 | Aortic regurgitation (HP:0001659) | 2.77569996 |
| 59 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.75116182 |
| 60 | Abnormality of the acetabulum (HP:0003170) | 2.73223164 |
| 61 | Vascular calcification (HP:0004934) | 2.71902789 |
| 62 | Large for gestational age (HP:0001520) | 2.69431069 |
| 63 | Spinal cord compression (HP:0002176) | 2.69300978 |
| 64 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.68494856 |
| 65 | Decreased circulating renin level (HP:0003351) | 2.65681535 |
| 66 | Abnormality of carpal bone ossification (HP:0006257) | 2.61822069 |
| 67 | Spondylolisthesis (HP:0003302) | 2.61096645 |
| 68 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.60489845 |
| 69 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.60489845 |
| 70 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.60489845 |
| 71 | Malnutrition (HP:0004395) | 2.57783662 |
| 72 | Complement deficiency (HP:0004431) | 2.56670774 |
| 73 | Hyperactive renin-angiotensin system (HP:0000841) | 2.54069155 |
| 74 | Blue sclerae (HP:0000592) | 2.53174538 |
| 75 | Bladder diverticulum (HP:0000015) | 2.49081530 |
| 76 | Short nail (HP:0001799) | 2.48898450 |
| 77 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.48739067 |
| 78 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.47550167 |
| 79 | Metabolic alkalosis (HP:0200114) | 2.47272651 |
| 80 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.45168925 |
| 81 | Spinal rigidity (HP:0003306) | 2.44685183 |
| 82 | Aneurysm (HP:0002617) | 2.43554309 |
| 83 | Protuberant abdomen (HP:0001538) | 2.42313636 |
| 84 | Hyperglycinuria (HP:0003108) | 2.41123542 |
| 85 | Hyperammonemia (HP:0001987) | 2.40567508 |
| 86 | Hypoalphalipoproteinemia (HP:0003233) | 2.40350146 |
| 87 | Genu recurvatum (HP:0002816) | 2.37488439 |
| 88 | Steatorrhea (HP:0002570) | 2.37444238 |
| 89 | Shallow orbits (HP:0000586) | 2.34920656 |
| 90 | Abnormality of chloride homeostasis (HP:0011422) | 2.33553670 |
| 91 | Dilatation of the ascending aorta (HP:0005111) | 2.33412635 |
| 92 | Abnormality of proline metabolism (HP:0010907) | 2.31735596 |
| 93 | Hydroxyprolinuria (HP:0003080) | 2.31735596 |
| 94 | Hypokalemia (HP:0002900) | 2.31174539 |
| 95 | Glycosuria (HP:0003076) | 2.31169809 |
| 96 | Abnormality of urine glucose concentration (HP:0011016) | 2.31169809 |
| 97 | Abnormal ossification of hand bones (HP:0005921) | 2.30645606 |
| 98 | Abnormality of dentin (HP:0010299) | 2.29480651 |
| 99 | Exocrine pancreatic insufficiency (HP:0001738) | 2.28364160 |
| 100 | Mitral stenosis (HP:0001718) | 2.25175869 |
| 101 | Overgrowth (HP:0001548) | 2.20588798 |
| 102 | Breech presentation (HP:0001623) | 2.17905150 |
| 103 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.17864933 |
| 104 | Flat capital femoral epiphysis (HP:0003370) | 2.17315038 |
| 105 | Hypophosphatemia (HP:0002148) | 2.16596929 |
| 106 | Dysostosis multiplex (HP:0000943) | 2.16316537 |
| 107 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.15995323 |
| 108 | Gout (HP:0001997) | 2.14956215 |
| 109 | Mitral valve prolapse (HP:0001634) | 2.14038212 |
| 110 | Abnormality of nucleobase metabolism (HP:0010932) | 2.13761923 |
| 111 | Abnormal hand bone ossification (HP:0010660) | 2.13622043 |
| 112 | Hyperlipoproteinemia (HP:0010980) | 2.12791703 |
| 113 | Congenital sensorineural hearing impairment (HP:0008527) | 2.12295852 |
| 114 | Abnormality of renin-angiotensin system (HP:0000847) | 2.11689131 |
| 115 | Abnormal delivery (HP:0001787) | 2.11283627 |
| 116 | Type 1 muscle fiber predominance (HP:0003803) | 2.11065762 |
| 117 | Hyperparathyroidism (HP:0000843) | 2.10995364 |
| 118 | Hyperextensible skin (HP:0000974) | 2.10894825 |
| 119 | Hyperaldosteronism (HP:0000859) | 2.10311838 |
| 120 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.09435641 |
| 121 | Villous atrophy (HP:0011473) | 2.09435641 |
| 122 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.09233460 |
| 123 | Hyperglycinemia (HP:0002154) | 2.07810762 |
| 124 | Vertebral compression fractures (HP:0002953) | 2.07383847 |
| 125 | Osteoarthritis (HP:0002758) | 2.06351904 |
| 126 | Renal tubular acidosis (HP:0001947) | 2.05350514 |
| 127 | * Conjugated hyperbilirubinemia (HP:0002908) | 2.04375169 |
| 128 | Widely patent fontanelles and sutures (HP:0004492) | 2.04042776 |
| 129 | Peritonitis (HP:0002586) | 2.03813672 |
| 130 | Abnormal tarsal ossification (HP:0008369) | 2.03336503 |
| 131 | Ovoid vertebral bodies (HP:0003300) | 2.01806265 |
| 132 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.99993335 |
| 133 | Abnormality of glycine metabolism (HP:0010895) | 1.99993335 |
| 134 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.98822628 |
| 135 | Metabolic acidosis (HP:0001942) | 1.98213640 |
| 136 | Tibial bowing (HP:0002982) | 1.97959027 |
| 137 | Hyperphosphaturia (HP:0003109) | 1.97814461 |
| 138 | Elevated alkaline phosphatase (HP:0003155) | 1.97763915 |
| 139 | Hypercholesterolemia (HP:0003124) | 1.97326772 |
| 140 | Abnormality of potassium homeostasis (HP:0011042) | 1.95467122 |
| 141 | Focal segmental glomerulosclerosis (HP:0000097) | 1.95445666 |
| 142 | Hemorrhage of the eye (HP:0011885) | 1.95426697 |
| 143 | Joint laxity (HP:0001388) | 1.95155379 |
| 144 | Alkalosis (HP:0001948) | 1.94579939 |
| 145 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.94375883 |
| 146 | Flattened epiphyses (HP:0003071) | 1.93354865 |
| 147 | Limb hypertonia (HP:0002509) | 1.93112315 |
| 148 | Distal upper limb amyotrophy (HP:0007149) | 1.92960817 |
| 149 | Upper limb amyotrophy (HP:0009129) | 1.92960817 |
| 150 | Joint hemorrhage (HP:0005261) | 1.91676414 |
| 151 | Abnormality of vitamin metabolism (HP:0100508) | 1.89521196 |
| 152 | Irritability (HP:0000737) | 1.88764536 |
| 153 | Retinal atrophy (HP:0001105) | 1.87752175 |
| 154 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.87425871 |
| 155 | Hoarse voice (HP:0001609) | 1.86358548 |
| 156 | Aortic valve stenosis (HP:0001650) | 1.85960144 |
| 157 | Chronic diarrhea (HP:0002028) | 1.85569652 |
| 158 | Abnormal foot bone ossification (HP:0010675) | 1.84553080 |
| 159 | Broad face (HP:0000283) | 1.83929290 |
| 160 | Osteomalacia (HP:0002749) | 1.83586615 |
| 161 | * Hyperbilirubinemia (HP:0002904) | 1.82255034 |
| 162 | Cerebral aneurysm (HP:0004944) | 1.81277791 |
| 163 | Chondrocalcinosis (HP:0000934) | 1.81009368 |
| 164 | Elbow flexion contracture (HP:0002987) | 1.80582167 |
| 165 | Abnormality of complement system (HP:0005339) | 1.79789137 |
| 166 | Absent frontal sinuses (HP:0002688) | 1.79322784 |
| 167 | Abnormal cartilage morphology (HP:0002763) | 1.79230136 |
| 168 | Nephrolithiasis (HP:0000787) | 1.78895948 |
| 169 | Esophageal varix (HP:0002040) | 1.78589501 |
| 170 | Long toe (HP:0010511) | 1.78120862 |
| 171 | Coxa vara (HP:0002812) | 1.76724252 |
| 172 | Femoral bowing (HP:0002980) | 1.75616485 |
| 173 | Hip contracture (HP:0003273) | 1.74954582 |
| 174 | Abnormality of Sharpey fibers (HP:0100685) | 1.74793114 |
| 175 | Mitral regurgitation (HP:0001653) | 1.73982919 |
| 176 | Abnormal vertebral ossification (HP:0100569) | 1.72141194 |
| 177 | Natal tooth (HP:0000695) | 1.71319001 |
| 178 | Hyperkalemia (HP:0002153) | 1.70519618 |
| 179 | Hyperphosphatemia (HP:0002905) | 1.69901785 |
| 180 | Abnormality of the phalanges of the hallux (HP:0010057) | 1.69846816 |
| 181 | Distal lower limb amyotrophy (HP:0008944) | 1.69741657 |
| 182 | Hemangiomatosis (HP:0007461) | 1.68493262 |
| 183 | Abnormal glucose tolerance (HP:0001952) | 1.66079465 |
| 184 | Visceral angiomatosis (HP:0100761) | 1.65535906 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 5.67589445 |
| 2 | INSRR | 5.42212868 |
| 3 | TAOK3 | 5.04318929 |
| 4 | ERN1 | 2.88174661 |
| 5 | MAPK15 | 2.70535560 |
| 6 | MAP3K2 | 2.67315205 |
| 7 | PASK | 2.59838428 |
| 8 | ACVR1B | 2.49316972 |
| 9 | LMTK2 | 2.28240407 |
| 10 | MST1R | 2.26742057 |
| 11 | LATS1 | 2.09449443 |
| 12 | PTK6 | 2.02830763 |
| 13 | AKT3 | 1.88576426 |
| 14 | PDGFRA | 1.82070910 |
| 15 | MAP2K2 | 1.78686359 |
| 16 | MET | 1.74448777 |
| 17 | IRAK3 | 1.71780054 |
| 18 | NUAK1 | 1.67952052 |
| 19 | MAP3K12 | 1.65560894 |
| 20 | BCKDK | 1.65509619 |
| 21 | TTN | 1.65480596 |
| 22 | TRPM7 | 1.59413132 |
| 23 | HIPK2 | 1.58533633 |
| 24 | WNK4 | 1.56154147 |
| 25 | PRKD3 | 1.56083175 |
| 26 | SIK1 | 1.53325665 |
| 27 | MAPKAPK3 | 1.50473471 |
| 28 | MAP3K1 | 1.45960863 |
| 29 | FLT3 | 1.44986559 |
| 30 | EPHA2 | 1.40120795 |
| 31 | SCYL2 | 1.39892926 |
| 32 | FGFR4 | 1.39578097 |
| 33 | PIK3CG | 1.39157905 |
| 34 | RIPK1 | 1.38446172 |
| 35 | MST4 | 1.37262369 |
| 36 | PRKG2 | 1.36988908 |
| 37 | PTK2 | 1.35312442 |
| 38 | PAK4 | 1.35104580 |
| 39 | STK38 | 1.22922373 |
| 40 | EPHA3 | 1.20586202 |
| 41 | ERBB4 | 1.18152253 |
| 42 | LIMK1 | 1.14684725 |
| 43 | STK38L | 1.10464101 |
| 44 | CDC42BPA | 1.08398837 |
| 45 | FER | 1.08032574 |
| 46 | STK24 | 1.01285126 |
| 47 | PIK3CA | 0.99988709 |
| 48 | DMPK | 0.92779438 |
| 49 | TRIB3 | 0.91361357 |
| 50 | OXSR1 | 0.90503118 |
| 51 | MAP3K3 | 0.87628972 |
| 52 | LATS2 | 0.85720598 |
| 53 | EPHB1 | 0.84706716 |
| 54 | PAK3 | 0.81352137 |
| 55 | NME1 | 0.80306728 |
| 56 | PRKAA1 | 0.78066934 |
| 57 | RPS6KA2 | 0.77271439 |
| 58 | MAP3K10 | 0.75325471 |
| 59 | PRKAA2 | 0.74591395 |
| 60 | JAK2 | 0.73816744 |
| 61 | STK39 | 0.72251181 |
| 62 | ABL2 | 0.72136549 |
| 63 | ROCK1 | 0.70956181 |
| 64 | NTRK1 | 0.70519209 |
| 65 | MYLK | 0.69357996 |
| 66 | WNK3 | 0.68693046 |
| 67 | DYRK1B | 0.68340004 |
| 68 | ERBB2 | 0.67988576 |
| 69 | JAK1 | 0.67305813 |
| 70 | GSK3A | 0.66993250 |
| 71 | IRAK1 | 0.66371493 |
| 72 | EEF2K | 0.65594779 |
| 73 | EIF2AK3 | 0.64977017 |
| 74 | PDGFRB | 0.64060448 |
| 75 | ICK | 0.63617010 |
| 76 | MAP2K1 | 0.62332925 |
| 77 | EPHB2 | 0.62083477 |
| 78 | PRKCH | 0.61951118 |
| 79 | PTK2B | 0.61198259 |
| 80 | FGFR2 | 0.60217786 |
| 81 | ILK | 0.59050678 |
| 82 | TIE1 | 0.57701811 |
| 83 | RET | 0.55654201 |
| 84 | TESK1 | 0.52432913 |
| 85 | PRKCI | 0.51046172 |
| 86 | FGFR3 | 0.50678477 |
| 87 | MAPK11 | 0.50661006 |
| 88 | CAMK2D | 0.49981081 |
| 89 | KDR | 0.49152185 |
| 90 | DDR2 | 0.48206605 |
| 91 | PDPK1 | 0.47475556 |
| 92 | PKN2 | 0.47244214 |
| 93 | ERBB3 | 0.45517253 |
| 94 | NEK9 | 0.45108428 |
| 95 | NLK | 0.44491938 |
| 96 | PRKACG | 0.44439034 |
| 97 | BRSK2 | 0.44363830 |
| 98 | PRKD1 | 0.42316942 |
| 99 | ADRBK1 | 0.42206378 |
| 100 | PRKCE | 0.41603211 |
| 101 | BMPR2 | 0.41264210 |
| 102 | NEK6 | 0.40260310 |
| 103 | ROCK2 | 0.39748186 |
| 104 | TESK2 | 0.39584276 |
| 105 | CAMKK2 | 0.39448245 |
| 106 | WNK1 | 0.38817248 |
| 107 | MAPKAPK2 | 0.38530110 |
| 108 | MELK | 0.38006844 |
| 109 | BMPR1B | 0.37324379 |
| 110 | MTOR | 0.37145386 |
| 111 | IGF1R | 0.36985177 |
| 112 | SMG1 | 0.36223319 |
| 113 | GRK1 | 0.34856559 |
| 114 | MAP3K7 | 0.34485781 |
| 115 | CDK12 | 0.34393691 |
| 116 | ITK | 0.33713127 |
| 117 | STK3 | 0.32488870 |
| 118 | SRC | 0.31900901 |
| 119 | IRAK2 | 0.31865080 |
| 120 | CAMK2G | 0.31397932 |
| 121 | PRKD2 | 0.31160738 |
| 122 | MAPK7 | 0.30810098 |
| 123 | CSNK1A1 | 0.30547833 |
| 124 | MAP3K6 | 0.29058112 |
| 125 | CSK | 0.28461474 |
| 126 | UHMK1 | 0.28374576 |
| 127 | PRKCA | 0.27949687 |
| 128 | CAMK2B | 0.26264989 |
| 129 | SGK3 | 0.23094048 |
| 130 | CHUK | 0.22884377 |
| 131 | TAOK1 | 0.22787305 |
| 132 | TGFBR2 | 0.22574135 |
| 133 | PAK2 | 0.21925834 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 6.15114289 |
| 2 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.93932613 |
| 3 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.93945891 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.69860582 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.43599310 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.36309243 |
| 7 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.36304177 |
| 8 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.28345829 |
| 9 | Protein export_Homo sapiens_hsa03060 | 2.28279283 |
| 10 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.05174376 |
| 11 | Histidine metabolism_Homo sapiens_hsa00340 | 1.89436875 |
| 12 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.87421342 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.82498246 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.78939161 |
| 15 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.77681472 |
| 16 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.77213757 |
| 17 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.72303500 |
| 18 | Bile secretion_Homo sapiens_hsa04976 | 1.67550414 |
| 19 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.64932235 |
| 20 | ABC transporters_Homo sapiens_hsa02010 | 1.63074994 |
| 21 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.57575012 |
| 22 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.57004388 |
| 23 | Focal adhesion_Homo sapiens_hsa04510 | 1.56039372 |
| 24 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.55868886 |
| 25 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.52758399 |
| 26 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.52108805 |
| 27 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.42450073 |
| 28 | Galactose metabolism_Homo sapiens_hsa00052 | 1.35774973 |
| 29 | Insulin secretion_Homo sapiens_hsa04911 | 1.33663068 |
| 30 | Tight junction_Homo sapiens_hsa04530 | 1.33620967 |
| 31 | Adherens junction_Homo sapiens_hsa04520 | 1.31670131 |
| 32 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.30533718 |
| 33 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.25480041 |
| 34 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.24012017 |
| 35 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.23052801 |
| 36 | Mineral absorption_Homo sapiens_hsa04978 | 1.22884199 |
| 37 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.22263366 |
| 38 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.21317668 |
| 39 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.19752715 |
| 40 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.18158403 |
| 41 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.14461074 |
| 42 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.14395118 |
| 43 | Peroxisome_Homo sapiens_hsa04146 | 1.12711374 |
| 44 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.12650696 |
| 45 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.12320269 |
| 46 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.06001315 |
| 47 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.05679110 |
| 48 | Amoebiasis_Homo sapiens_hsa05146 | 1.05425994 |
| 49 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.04019206 |
| 50 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.03096335 |
| 51 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.97973688 |
| 52 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.97601588 |
| 53 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.97591010 |
| 54 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.97130329 |
| 55 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.95699386 |
| 56 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.95598176 |
| 57 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.94571935 |
| 58 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.93692059 |
| 59 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.91927267 |
| 60 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.91457887 |
| 61 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.91124890 |
| 62 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.86571651 |
| 63 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.86546332 |
| 64 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.86158740 |
| 65 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.84861427 |
| 66 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.81439164 |
| 67 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.81306375 |
| 68 | Retinol metabolism_Homo sapiens_hsa00830 | 0.80004998 |
| 69 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.77535698 |
| 70 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.77448380 |
| 71 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.76099498 |
| 72 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.75919794 |
| 73 | Insulin resistance_Homo sapiens_hsa04931 | 0.75721751 |
| 74 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.75538961 |
| 75 | Lysine degradation_Homo sapiens_hsa00310 | 0.72440272 |
| 76 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.72217480 |
| 77 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.71946094 |
| 78 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.71551924 |
| 79 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.70763819 |
| 80 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.63591966 |
| 81 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.63197619 |
| 82 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.62650714 |
| 83 | Renin secretion_Homo sapiens_hsa04924 | 0.61855008 |
| 84 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.61214579 |
| 85 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.60289214 |
| 86 | Hepatitis C_Homo sapiens_hsa05160 | 0.57629422 |
| 87 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.57262179 |
| 88 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.56370470 |
| 89 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.56324189 |
| 90 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.55952205 |
| 91 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.53966434 |
| 92 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.53858181 |
| 93 | Thyroid cancer_Homo sapiens_hsa05216 | 0.53181700 |
| 94 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.51576548 |
| 95 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.49581757 |
| 96 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.49136327 |
| 97 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.48655731 |
| 98 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.47416331 |
| 99 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.43836292 |
| 100 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.42248042 |
| 101 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.41549335 |
| 102 | Other glycan degradation_Homo sapiens_hsa00511 | 0.40004793 |
| 103 | Prostate cancer_Homo sapiens_hsa05215 | 0.39827360 |
| 104 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.39732867 |
| 105 | Lysosome_Homo sapiens_hsa04142 | 0.38601544 |
| 106 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.38414899 |
| 107 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.38266853 |
| 108 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.37778699 |
| 109 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.37361635 |
| 110 | Carbon metabolism_Homo sapiens_hsa01200 | 0.36253153 |
| 111 | Prion diseases_Homo sapiens_hsa05020 | 0.36060047 |
| 112 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.34643001 |
| 113 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.33665946 |
| 114 | Endocytosis_Homo sapiens_hsa04144 | 0.33367083 |
| 115 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.32351562 |
| 116 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.32269210 |
| 117 | Metabolic pathways_Homo sapiens_hsa01100 | 0.31653905 |
| 118 | Cocaine addiction_Homo sapiens_hsa05030 | 0.31066773 |
| 119 | Melanoma_Homo sapiens_hsa05218 | 0.30036623 |
| 120 | Pathways in cancer_Homo sapiens_hsa05200 | 0.29313968 |
| 121 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.28784675 |
| 122 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.28486468 |
| 123 | Platelet activation_Homo sapiens_hsa04611 | 0.27062842 |
| 124 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.26854201 |
| 125 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.26344500 |
| 126 | Bladder cancer_Homo sapiens_hsa05219 | 0.26220697 |
| 127 | Gap junction_Homo sapiens_hsa04540 | 0.24650348 |
| 128 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.24640736 |
| 129 | Circadian rhythm_Homo sapiens_hsa04710 | 0.23812272 |
| 130 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.21505040 |
| 131 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.19745247 |
| 132 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.19708518 |
| 133 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.18762613 |
| 134 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.16302403 |
| 135 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.15684259 |
| 136 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.15634424 |
| 137 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.15253010 |

